<DOC>
	<DOCNO>NCT00681629</DOCNO>
	<brief_summary>The purpose study investigate well-being schizophrenic patient treat quetiapine XR combine participation integrate care program compare treatment quetiapine XR alone period 18 month</brief_summary>
	<brief_title>Schizophrenic Patients Integrated Care</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Patients baseline SWNK &lt; =70 Provision sign informed consent Outpatients schizophrenia , schizophreniform disorder schizoaffective disorder , severe postpartum depressive disorder psychotic symptom minimum HAMD cut score 20 point Evidence clinical relevant disease , eg renal hepatic impairment , significant coronary heart disease , hepatitis B C , AIDS Patients know cardiovascular disease condition predispose hypotension family history QT prolongation Patients pose imminent risk suicide danger self others</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Integrated Care</keyword>
	<keyword>Quetiapine</keyword>
</DOC>